glp-1 treatment gonzales medications safe to continue before surgery in patients with diabetes and obesity The weight-loss-independent hepatoprotective benefits of

Im Flora Lichtman, and youre listening to Science Friday

For context, GLP-1s are only FDA-approved for people whose BMI is at least 30, or for people with a BMI of 27 and who have a weight-related health condition

The key differences: the FDA has not reviewed compounded semaglutide preparations for safety, effectiveness, or quality as finished products

Board-Certified Dr

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet and behaviours, and executive chair and former CEO Saeju Jeong said the move into providing semaglutide is "in line with our mission to help everyone everywhere live better longer." The company is offering compounded semaglutide for $149 for the first month and $279 for subsequent months, pairing the supply of the drug to its digital health platform to create a system that can achieve "sustainable, long-term weight loss" and help people eventually taper off treatment whilst keeping the weight off, said Jeong in a LinkedIn post